The purpose of the FDA letter was to inform the National Association of Boards of Pharmacy (NABP) that during inspections the FDA was starting to notice compounders utilizing Semaglutide Acetate and Semaglutide Sodium (ie the salts) in substitute for Semaglutide (base)
Participants also showed improvements in cardiovascular risk factors, including waist circumference, non-HDL cholesterol, triglycerides, systolic blood pressure, and high-sensitivity C-reactive protein (hsCRP)
Biliary excretion accounts for 80% or more of copper elimination from the body [5]
For injectable semaglutide formulations, most compounding pharmacies pair semaglutide with cyanocobalamin (vitamin B12)
He adds that SURMOUNT-MMO is also worth watching for a number of its secondary outcomes, including time to onset of type 2 diabetes, renal death or end-stage renal disease, and a variety of quality-of-life measures